Abstract
PC-cell derived growth factor (PCDGF) is an 88-kDa growth factor originally purified from the highly tumorigenic teratoma PC cell line and corresponds to the epithelin/granulin precursor. In teratoma cells, PCDGF expression was shown to be essential for tumorigenicity. We have reported that PCDGF was expressed in estrogen receptor-positive (ER + ) human mammary epithelial cells in an estrogen-dependent fashion. In this study, we have investigated PCDGF expression in human mammary epithelial cell lines ranging from immortalized nontumorigenic cells to ER + and ER − breast carcinoma cells. Northern and Western blot analyses indicated that PCDGF mRNA and protein expression was low in nontumorigenic cells and increased in human breast carcinomas cell lines in a positive correlation with their tumorigenicity. Treatment of the ER − MDA-MB-468 cells with anti-PCDGF neutralizing antibody resulted in a dose-dependent inhibition of their proliferation, suggesting that secreted PCDGF acted as an autocrine growth factor for breast carcinoma cells. We then examined the in vitro and in vivo growth properties of MDA-MB-468 cells, where PCDGF expression had been inhibited by antisense PCDGF cDNA transfection. Inhibition of PCDGF expression resulted in a reduced proliferation rate in vitro and a 60–80% reduction in colony formation. Tumor formation in vivo was dramatically inhibited in antisense cells with a 90% inhibition of tumor incidence and tumor weight. These results demonstrate the importance of PCDGF overexpression for the proliferation and tumorigenicity of ER − breast carcinomas and suggest that PCDGF overexpression may play an important role in human breast cancer.
Bibliography
Lu, R., & Serrero, G. (2000). Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proceedings of the National Academy of Sciences, 97(8), 3993â3998.
References
42
Referenced
106
10.1210/er.19.4.365
10.1007/BF00666179
10.1210/edrv-16-5-559
10.1126/science.1659742
10.1038/313745a0
- A B Roberts, M B Sporn Cancer Surv 4, 683–705 (1985). / Cancer Surv by Roberts A B (1985)
10.1056/NEJM198010093031511
10.1002/mc.2940020102
- F Ciardiello, M L McGeady, N Kim, F Basolo, N Hynes, B C Langton, H Yokozaki, T Saeki, J W Elliott, H Masui, et al. Cell Growth Differ 1, 407–420 (1990). / Cell Growth Differ by Ciardiello F (1990)
10.1016/0092-8674(90)90075-P
- S L Fitzpatrick, J Brightwell, J L Wittliff, G H Barrows, G S Schultz Cancer Res 44, 3448–3453 (1984). / Cancer Res by Fitzpatrick S L (1984)
10.1200/JCO.1996.14.3.737
- L M Weiner, J I Clark, M Davey, W S Li, I Garcia de Palazzo, D B Ring, R K Alpaugh Cancer Res 55, 4586–4593 (1995). / Cancer Res by Weiner L M (1995)
- C L Arteaga, C K Osborne Cancer Res 49, 6237–6241 (1989). / Cancer Res by Arteaga C L (1989)
10.1074/jbc.271.19.11477
10.1016/0092-8674(90)90077-R
10.1074/jbc.273.43.28155
10.1128/MCB.19.1.321
10.1016/S0021-9258(18)82064-6
10.1073/pnas.89.5.1715
10.1677/joe.0.1580145
10.1016/S0021-9258(18)82221-9
10.1016/S0021-9258(18)98340-7
10.1016/S0021-9258(18)42382-4
- Z He, A Bateman Cancer Res 59, 3222–3229 (1999). / Cancer Res by He Z (1999)
10.1074/jbc.273.32.20078
10.1006/bbrc.1998.8498
10.1073/pnas.95.24.14202
10.1006/bbrc.1999.0253
- H D Soule, T M Maloney, S R Wolman, W D Peterson, R Brenz, C M McGrath, J Russo, R J Pauley, R F Jones, S C Brooks Cancer Res 50, 6075–6086 (1990). / Cancer Res by Soule H D (1990)
- D D Boyd, A E Levine, D E Brattain, M K McKnight, M G Brattain Cancer Res 48, 2469–2474 (1988). / Cancer Res by Boyd D D (1988)
10.1002/bies.950131109
10.1016/1040-8428(94)00161-L
10.1002/jcp.1041490321
10.1073/pnas.87.20.7912
10.1016/S0006-291X(05)80908-8
10.1006/prep.1997.0726
10.1002/jcp.1041560309
- K B Reddy, D Yee, S G Hilsenbeck, R J Coffey, C K Osborne Cell Growth Differ 5, 1275–1282 (1994). / Cell Growth Differ by Reddy K B (1994)
10.1126/science.8418502
10.1073/pnas.89.11.4874
- J Wu Anticancer Res 16, 2233–2239 (1996). / Anticancer Res by Wu J (1996)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:40 a.m.) |
Deposited | 3 years, 4 months ago (April 13, 2022, 5:11 p.m.) |
Indexed | 3 weeks, 6 days ago (Aug. 6, 2025, 9 a.m.) |
Issued | 25 years, 4 months ago (April 11, 2000) |
Published | 25 years, 4 months ago (April 11, 2000) |
Published Online | 25 years, 4 months ago (April 11, 2000) |
Published Print | 25 years, 4 months ago (April 11, 2000) |
@article{Lu_2000, title={Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468}, volume={97}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.97.8.3993}, DOI={10.1073/pnas.97.8.3993}, number={8}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Lu, Runqing and Serrero, Ginette}, year={2000}, month=apr, pages={3993–3998} }